Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in VERU — Veru Inc.

CIK 1446194 BALA CYNWYD, PA
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$39,428
+$11,205 QoQ
Shares Held
12,597
-1.4% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Derivatives in VERU

reported options exposure · as of Jun 30, 2026
CallValue
$295,472
CallShares
94,400
PutValue
$233,498
PutShares
74,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. VERU ranks #300 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in VERU

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $295,472 94,400
2026-06-30 $39,428 12,597
2026-06-30 $233,498 74,600
2026-03-31 $22,542 10,200
2026-03-31 $28,223 12,771
2025-12-31 $37,430 17,491
2025-09-30 $254,330 66,929
2025-09-30 $259,160 68,200
2025-06-30 $378,255 652,165
2025-06-30 $251,082 432,900
2025-03-31 $43,218 88,200
2025-03-31 $801,395 1,635,500
2025-03-31 $255,318 521,058
2024-12-31 $213,643 328,683
2024-12-31 $236,795 364,300
2024-12-31 $147,095 226,300
2024-09-30 $71,353 92,667
2024-09-30 $183,260 238,000
2024-09-30 $174,020 226,000
2024-06-30 $177,072 210,800
2024-06-30 $79,044 94,100
2024-06-30 $284,934 339,208
2024-03-31 $204,960 292,800
2024-03-31 $674,201 963,145
2024-03-31 $42,000 60,000
2023-12-31 $264,888 367,900
2023-12-31 $181,164 251,618
2023-12-31 $32,040 44,500
2023-09-30 $68,668 95,373
2023-09-30 $53,280 74,000
2023-09-30 $302,976 420,800
2023-06-30 $275,646 231,636
2023-06-30 $591,192 496,800
2023-06-30 $353,192 296,800
2023-03-31 $292,088 251,800
2023-03-31 $1,026,252 884,700
2023-03-31 $166,043 143,141
2022-12-31 $9,326,592 1,766,400
2022-12-31 $2,412,432 456,900
2022-12-31 $120,088 22,744
2022-09-30 $224,939 19,526
2022-09-30 $22,629,888 1,964,400
2022-09-30 $27,922,176 2,423,800
2022-06-30 $7,846,720 694,400
2022-06-30 $14,708,080 1,301,600
2022-03-31 $2,320,076 480,347
2022-03-31 $1,185,765 245,500
2022-03-31 $1,150,989 238,300
2021-12-31 $3,837,099 651,460
2021-12-31 $918,840 156,000